Narin researches cognitive and motor network differences in asymptomatic carriers of the C9orf72 hexanucleotide repeat expansion and other genes associated with ALS. She joined the McMackin Lab in 2023, focusing on EEG and TMS-based measures to investigate subtypes of ALS. Alongside her research work, Narin is a medical doctor and currently works in the National ALS Service at Beaumont Hospital. Narin's research interests broadly lie at the intersection of technology and neurology.